Neuroleptique And NotW. H. Oertel
List of bibliographic references
Number of relevant bibliographic references: 75.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000380 | Maria Sierra Pena [États-Unis] ; Toby C. Yaltho [États-Unis] ; Joseph Jankovic [États-Unis] | Tardive Dyskinesia and Other Movement Disorders Secondary to Aripiprazole |
| 000619 | Richard A. Walsh [Canada] ; Anthony E. Lang [Canada] | Early-Onset Tardive Dyskinesia in a Neuroleptic-Naive Patient Exposed to Low-Dose Quetiapine |
| 000622 | Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France] | Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France |
| 000946 | P. Ken Gillman [Australie] ; Mrc Psych [Australie] | Neuroleptic Malignant Syndrome: Mechanisms, Interactions, and Causality |
| 000C74 | Livia Brusa [Italie] ; Antonio Orlacchio [Italie] ; Vincenzo Moschella [Italie] ; Cesare Iani [Italie] ; Giorgio Bernardi [Italie] ; Nicola Biagio Mercuri [Italie] | Treatment of the Symptoms of Huntington's Disease : Preliminary Results Comparing Aripiprazole and Tetrabenazine |
| 000D27 | Susanne A. Schneider [Royaume-Uni] ; Vrajesh Udani [Inde] ; Charulata Sawant Sankhla [Inde] ; Kailash P. Bhatia [Royaume-Uni] | Recurrent Acute Dystonic Reaction and Oculogyric Crisis Despite Withdrawal of Dopamine Receptor Blocking Drugs |
| 001964 | Mattia Gambarin [Italie] ; Angelo Antonini [Italie] ; Giuseppe Moretto [Italie] ; Paolo Bovi [Italie] ; Silvia Romito [Italie] ; Antonio Fiaschi [Italie] ; Michele Tinazzi [Italie] | Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease : Case report |
| 001A84 | Katie Kompoliti [États-Unis] ; Christopher G. Goetz [États-Unis] ; Mary Morrissey [États-Unis] ; Sue Leurgans [États-Unis] | Gilles de la tourette syndrome : Patient's knowledge and concern of adverse effects |
| 001B08 | Daniel Tarsy [États-Unis] ; Ross J. Baldessarini [États-Unis] | Epidemiology of tardive dyskinesia : Is risk declining with modern antipsychotics? |
| 001D85 | Jong-Hoon Kim [Corée du Sud] ; Young-Ho Jin [Corée du Sud] ; UNG GU KANG [Corée du Sud] ; YONG MIN AHN [Corée du Sud] ; Kyoo-Seob Ha [Corée du Sud] ; YONG SIK KIM [Corée du Sud] | Neuroleptic-induced acute and chronic akathisia : A clinical comparison |
| 001D96 | Nicte I. Mejia [États-Unis] ; Joseph Jankovic [États-Unis] | Metoclopramide-induced tardive dyskinesia in an infant |
| 002298 | Anjan Chatterjee [États-Unis] ; Steven J. Frucht [États-Unis] | Tetrabenazine in the treatment of severe pediatric chorea |
| 002352 | Werner Poewe [Autriche] | Psychosis in Parkinson's disease |
| 002414 | Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Monica A. Burke [États-Unis] ; Carol Jacques [États-Unis] ; Joseph H. Friedman [États-Unis] | Long-term outcome of quetiapine use for psychosis among parkinsonian patients |
| 002584 | Sujana Reddy [États-Unis] ; Stewart A. Factor [États-Unis] ; Eric S. Molho [États-Unis] ; Paul J. Feustel [États-Unis] | The effect of quetiapine on psychosis and motor function in Parkinsonian patients with and without dementia |
| 002672 | William G. Ondo [États-Unis] ; Joel K. Levy [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis] | Olanzapine treatment for dopaminergic-induced hallucinations |
| 002825 | Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra [États-Unis] ; Robert A. Hauser [États-Unis] | Clozapine withdrawal symptoms in a Parkinson's disease patient |
| 002881 | Han-Cheng Wang [Taïwan] ; YOLOUNG HSIEH [Taïwan] | Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy |
| 002949 | P. H. Gordon [États-Unis] ; S. J. Frucht [États-Unis] | Neuroleptic malignant syndrome in advanced Parkinson's disease |
| 002A33 | Stewart A. Factor [États-Unis] ; Joseph H. Friedman [États-Unis] ; Margaret C. Lannon [États-Unis] ; David Oakes [États-Unis] ; Keith Bourgeois [États-Unis] | Clozapine for the treatment of drug-induced psychosis in Parkinson's disease : Results of the 12 week open label extension in the PSYCLOPS trial |
| 002B22 | N. A. Leopold [États-Unis] | Risperidone treatment of drug-related psychosis in patients with Parkinsonism |
| 002B23 | Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique] | Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial |
| 002C32 | H. H. Fernandez [États-Unis] ; M. C. Lannon [États-Unis] ; J. H. Friedman [États-Unis] ; B. P. Abbott [États-Unis] | Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease |
| 002C46 | A. Rapaport [Israël] ; M. Sadeh [Israël] ; D. Stein [Israël] ; J. Levine [Israël] ; P. Sirota [Israël] ; T. Mosheva [Israël] ; S. Stir [Israël] ; A. Elitzur [Israël] ; I. Reznik [Israël] ; D. Geva [Israël] ; J. M. Rabev [Israël] | Botulinum toxin for the treatment of oro-facial-lingual-masticatory tardive dyskinesia |
| 002C54 | J. H. Friedman [États-Unis] ; S. A. Factor | Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease |
| 002C87 | E. S. Molho [États-Unis] ; S. A. Factor [États-Unis] | Worsening of motor features of Parkinsonism with olanzapine |
| 002D11 | B. Safirstein [États-Unis] ; L. M. Shulman [États-Unis] ; W. J. Weiner [États-Unis] | Successful treatment of hemichorea with olanzapine |
| 002D28 | V. G. H. Evidente [États-Unis, Philippines] ; K. Gwinn-Hardy [États-Unis] ; J. N. Caviness [États-Unis] ; C. H. Adler [États-Unis] | Risperidone is effective in severe hemichorea/hemiballismus |
| 002D30 | W. Meissner [Allemagne] ; T. Schmidt [Allemagne] ; A. Kupsch [Allemagne] ; T. Trottenberg [Allemagne] ; T. Lempert [Allemagne] | Reversible leucopenia related to olanzapine |
| 002D34 | H. H. Fernandez [États-Unis] ; J. H. Friedman [États-Unis] ; C. Jacques [États-Unis] ; M. Rosenfeld [États-Unis] | Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease |
| 002D45 | E. S. Molho [États-Unis] ; S. A. Factor [États-Unis] | Possible tardive dystonia resulting from clozapine therapy |
| 002D48 | G. Lera [Argentine] ; J. Zirulnik [Argentine] | Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced Parkinsonism |
| 002D93 | N. Giladi [Israël] ; E. Melamed [Israël] | Levodopa therapy can ameliorate tetrabenazine-induced parkinsonism |
| 002E55 | G. Northoff [Allemagne] ; A. Koch [Allemagne] ; J. Wenke [Allemagne] ; J. Eckert [Allemagne] ; H. Böker [Allemagne] ; B. Pflug [Allemagne] ; B. Bogerts [Allemagne] | Catatonia as a psychomotor syndrome : A rating scale and extrapyramidal motor symptoms |
| 002E71 | B. I. Karp [États-Unis, Canada] ; S. R. Goldstein [États-Unis, Canada] ; R. Chen [États-Unis, Canada] ; A. Samii [États-Unis] ; W. Bara-Jimenez [États-Unis, Canada] ; M. Hallett [États-Unis, Canada] | An open trial of clozapine for dystonia |
| 002E73 | R. Ceravolo [Italie] ; S. Salvetti [Italie] ; P. Piccini [Royaume-Uni] ; C. Lucetti [Italie] ; G. Gambaccini [Italie] ; U. Bonuccelli [Italie] | Acute and chronic effects of clozapine in essential tremor |
| 002F16 | D. J. Burn [Royaume-Uni] ; A. Coulthard [Royaume-Uni] ; S. Connolly [Royaume-Uni] ; N. E. F. Cartlidge [Royaume-Uni] | Tardive diaphragmatic flutter |
| 002F17 | P. Sachdev [Australie] | Tardive blepharospasm |
| 002F54 | S. M. Mirsattari [Canada] ; C. Power [Canada] ; A. Nath [Canada, États-Unis] | Parkinsonism with HIV infection |
| 003034 | J. Warren [Australie] ; P. Thompson [Australie] | Drug-induced supraglottic dystonia and spasmodic dysphonia |
| 003057 | R. M. Trosch [États-Unis] ; J. H. Friedman [États-Unis] ; M. C. Lannon [États-Unis] ; R. Pahwa [États-Unis] ; D. Smith [États-Unis] ; L. C. Seeberger [États-Unis] ; C. F. O'Brien [États-Unis] ; P. A. Lewitt [États-Unis] ; W. C. Koller [États-Unis] | Clozapine use in Parkinson's disease : A retrospective analysis of a large multicentered clinical experience |
| 003058 | I. Maurer [Allemagne] ; T. Grunwald [Allemagne] ; C. E. Elger [Allemagne] | Clozapine treatment of delayed-onset paroxysmal hemidystonia |
| 003059 | H. H. Fernandez [États-Unis] ; R. Durso [États-Unis] | Clozapine for dopaminergic-induced paraphilias in Parkinson's disease |
| 003089 | R. Kurlan [États-Unis] | Acute parkinsonism induced by the combination of a serotonin reuptake inhibitor and a neuroleptic in adults with Tourette's syndrome |
| 003099 | F. Delecluse [Belgique] ; J. A. Elosegi [Belgique] ; J.-M. Gerard [Belgique] | A case of tardive tremor successfully treated with clozapine |
| 003126 | S. A. Factor [États-Unis] ; J. H. Friedman [États-Unis] | The emerging role of clozapine in the treatment of movement disorders |
| 003198 | G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. T. Savino [Argentine] ; M. Mora [Argentine] ; F. J. E. Stefano [Argentine] ; O. Gershanik [Argentine] | Mechanism of action of clozapine-induced modification of motor behavior in an animal model of the "super-off" phenomenon |
| 003296 | G. M. Petzinger [États-Unis] ; S. B. Bressman [États-Unis] | A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment |
| 003314 | M. Raja [Italie] ; G. Maisto [Italie] ; M. C. Altavista [Italie] ; A. Albanese [Italie] | Tardive lingual dystonia treated with clozapine |
| 003359 | M. Jauss [Allemagne] ; P. Krack [Allemagne] ; M. Franz [Allemagne] ; R. Klett [Allemagne] ; R. Bauer [Allemagne] ; B. Gallhofer [Allemagne] ; W. Dorndorf [Allemagne] | Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome |
| 003442 | K. J. Bharucha [États-Unis] ; K. D. Sethi | Tardive tourettism after exposure to neuroleptic therapy |
| 003548 | A. E. Lang [Canada] | Withdrawal akathisia: case reports and a proposed classification of chronic akathisia |
| 003559 | J. M. Trugman [États-Unis] ; R. Leadbetter ; M. E. Zalis ; R. O. Burgdorf ; G. F. Wooten [États-Unis] | Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis |
| 003570 | J. P. Jr Bennett [États-Unis] ; E. R. Landow ; S. Dietrich ; L. A. Schuh | Suppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction |
| 003631 | J. H. Friedman [États-Unis] | Clozapine treatment of psychosis in patients with tardive dystonia: report of three cases |
| 003669 | A. J. Stoessl [Canada] ; E. Polanski ; H. Frydryszak | The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia |
| 003673 | P. Sachdev [Australie] | Tardive and chronically recurrent oculogyric crises |
| 003696 | A. Feve [France] ; B. Angelard [France] ; G. Fenelon [France] ; M. Logak [France] ; A. Guillard [France] ; J. Lacau Saint-Guily | Postneuroleptic laryngeal dyskinesias: a cause of upper airway obstructive syndrome improved by local injections of botulinum toxin |
| 003706 | G. Linazasoro [Espagne] ; J. F. Marti Masso ; J. A. Suarez | Nocturnal akathisia in Parkinson's disease: treatment with clozapine |
| 003713 | G. J. Gomez Arevalo [Argentine] ; O. S. Gershanik | Modulator effect of clozapine on levodopa response in Parkinson's disease: a preliminary study |
| 003774 | M. Stacy [États-Unis] ; Joseph Jankovic [États-Unis] | Tardive tremor |
| 003778 | J. H. Friedman [États-Unis] | Rubral' tremor induced by a neuroleptic drug |
| 003779 | I. J. Mitchell [Royaume-Uni] ; A. R. Crossman ; U. Liminga ; P. Andren ; L. M. Gunne | Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the cebus monkey |
| 003919 | A. Achiron ; E. Melamed | Tardive eating dystonia |
| 003928 | K. D. Sethi ; D. C. Hess ; R. J. Harp | Prevalence of dystonia in veterans on chronic antipsychotic therapy |
| 003930 | K. D. Sethi ; A. Hitri ; B. I. Diamond | Phenytoin potentiation of neuroleptic-induced dyskinesias |
| 003936 | M. E. Rodriguez ; M. R. Luquin ; G. Lera ; G. Delgado ; J. M. Salazar ; J. A. Obeso | Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion |
| 003961 | J. H. Friedman ; M. C. Lannon | Clozapine-responsive tremor in Parkinson's disease |
| 003962 | R. F. Pfeiffer ; J. Kang ; B. Graber ; R. Hofman ; J. Wilson | Clozapine for psychosis in Parkinson's disease |
| 003991 | U. Andersson ; J.-E. Haggstrom ; E. D. Levin ; U. Bondesson ; M. Valverius ; L. M. Gunne | Reduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesia |
| 003A04 | W. S. Metzer ; J. E. O. Newton ; R. W. Steele ; M. Claybrook ; S. R. Paige ; D. E. Mcmillan ; S. Hays | HLA Antigens in drug-induced Parkinsonism |
| 003A15 | M. Deahl | Betel nut-induced ectrapyramidal syndrome: an unusual drug interaction |
| 003A16 | L. E. Adler ; M. Pecevich ; H. Nagamoto | Bereitschaftspotential in tardive dyskinesia |
| 003A32 | S. K. Singh ; Joseph Jankovic [États-Unis] | Tardive dystonia in patients with Tourette's syndrome |
| 003A69 | C. G. Goetz ; K. M. Shannon ; V. S. Carroll ; C. M. Tanner ; R. Weingarten | The autonomic nervous system in Gilles de la Tourette's syndrome |
| This area was generated with Dilib version V0.6.23. |  |